News
RESI Innovator’s Pitch Challenge Winner
Concarlo wins the Innovator’s Pitch Challenge at RESI Jan 2021!
Targeting p27Kip1 to Treat Drug-Resistance Cancer
Stacy Blain, PhD, Founder, CSO and CEO
US biotech start-up set to have huge impact on breast cancer treatment landscape
Click to read the Drug Discovery World article about Concarlo, also featured in their fall issue.
Concarlo: targeting proliferation and resistance in one go
Click to read the BioCentury Emerging Company Profile.
Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer
Click to read the Life Science Newswire press release.
TigerTalks in the City: How Genomics Are Driving Novel Therapies
Stacy was a panelist at Princeton Entrepreneurship Council’s popular panel discussion series. Click to learn more.
2019 Social Enterprise Conference
Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.
WE NYC Women in Tech Conference
Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.
Impact Journals: March 2019
Click here to download the manuscript: Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Proactive Investors Interview
At the 11th Annual Biotech Showcase in San Francisco
Women & Wealth Magazine: 18 Women to Watch in 2018
Features Dr. Stacy Blain, Co-Founder and Chief Scientific Officer, Concarlo Holdings
SUNY Downstate Medical Center Press Release
SUNY Downstate Startup Company Secures Over $1 Million in Seed Funding Investment for Advancement of Proprietary Cancer Companion Diagnostic Test
Impact Journals: Oncoscience May 2018
Click here to download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.
Molecular Cancer Research Journal: March 2018
Click here to download Stacy and Priyank’s article:
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Student Visit from Edsnaps
Increasing diversity in the science technology engineering & mathematics (STEM) workforce.
Research Associate Sarah Teed, M.S. welcomes young students to learn more about Concarlo’s mission.